Advertisement

RFK Jr. Says New HHS Decisions No Longer Required to Be Open for Public...

0

Newly appointed health secretary believes processing the comments under the Richardson Waiver puts too heavy a burden on the department

Obinutuzumab Efficacious for Renal Response in Lupus Nephritis

0

More patients receiving obinutuzumab plus standard therapy versus standard therapy alone had a complete renal response at week 76

Anifrolumab Tied to Less Organ Damage for Patients With Lupus

0

Lower likelihood seen for experiencing increase in Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index

Chronic Medical Conditions Take Toll on Employees

0

Survey reveals employees do not always prioritize their health over work

Intermittent Fasting Aids Some Outcomes for Postmenopausal Women With RA

0

Benefits seen for oxidative stress markers, inflammatory indices, and liver enzymes

FDA Approves First New Non-Opioid Pain Pill in Decades

0
By India Edwards HealthDay Reporter FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain...

Age at First Birth May Influence Later Rheumatoid Arthritis Risk

0

Higher risk seen for women with an age at first birth younger than 26 or older than 35 years

Rheumatoid Arthritis Causally Linked to Prostate Cancer

0

No significant associations seen for SLE or AS with prostate cancer or in reverse MR analyses

Childhood Maltreatment May Up Risk for Immune-Mediated Inflammatory Disorders

0

Significantly higher risk seen for rheumatoid arthritis and psoriasis

GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss

0

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders